Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy

References

• Argento, E., Strathdee, S. A., Tupper, K., Braschel, M., Wood, E., & Shannon, K. (2017). Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting. BMJ Open, 7, e016025. doi:10.1136/bmjopen-2017-016025
   PubMed Web of Science ®Google Scholar
• Bai, Y., Maruskin, L. A., Chen, S., Gordon, A. M., Stellar, J. E., McNeil, G. D., … Keltner, D. (2017). Awe, the diminished self, and collective engagement: Universals and cultural variations in the small self. Journal of Personality and Social Psychology, 113, 185–209. doi:10.1037/pspa0000087
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M.S., Johnson, M. W., & Griffiths, R. R. (2016). The challenging experience questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford), 30, 1279–1295. doi:10.1177/0269881116678781
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., & Griffiths, R. R. (2018). Classic hallucinogens and mystical experiences: Phenomenology and neural correlates. Current Topics in Behavioral Neurosciences, 36, 393–430. doi:10.1007/7854_2017_474
   PubMedGoogle Scholar
• Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015). Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford), 29, 1182–1190. doi:10.1177/0269881115609019
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2017). Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences, 117, 155–160. doi:10.1016/j.paid.2017.06.004
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., Robbins, H., Smooke, D., Brown, J. L., & Griffiths, R. R.. (2017). Qualitative and quantitative features of music reported to support peak mystical experiences during psychedelic therapy sessions. Frontiers in Psychology, 8, 1238. doi:10.3389/fpsyg.2017.01238
   PubMed Web of Science ®Google Scholar
• Bogar, S., & Beyer, K. M. (2016). Green space, violence, and crime: A systematic review. Trauma, Violence, & Abuse, 17, 160–171. doi:10.1177/1524838015576412
   PubMed Web of Science ®Google Scholar
• Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C. R., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology (Oxford), 29, 289–299. doi:10.1177/0269881114565144
   PubMed Web of Science ®Google Scholar
• Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford), 30, 1268–1278. doi:10.1177/0269881116662634
   PubMed Web of Science ®Google Scholar
• Carbonaro, T. M., Johnson, M. W., & Hurwitz, E. (2018). Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: Similarities and differences in subjective experiences. Psychopharmacology, 235, 521–534. doi:10.1007/s00213-017-4769-4
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Bolstridge, M., & Day, C. M. J. (2018). Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Psychopharmacology, 235, 399–408. doi:10.1007/s00213-017-4771-x
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., … Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry, 3, 619–627. doi:10.1016/S2215-0366(16)30065-7
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Erritzoe, D., & Haijen, E. (2018). Psychedelics and connectedness. Psychopharmacology, 235, 547–550. doi:10.1007/s00213-017-4701-y
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., … Nutt, D. (2014). The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in human neuroscience, 8, 20. doi:10.3389/fnhum.2014.00020
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences of the United States of America, 113, 4853–4858. doi:10.1073/pnas.1518377113
   PubMed Web of Science ®Google Scholar
• Corey, G. (2015) Family systems therapy. In Theory and practice of counseling and psychotherapy (pp. 403–425). Boston, MA: Cengage Learning.
   Google Scholar
• Doblin, R. (1991). Pahnke’s “Good Friday Experiment”: A long-term follow-up and methodological critique. Journal of Transpersonal Psychology, 23, 1–28.
   Google Scholar
• Droit-Volet, S., Fanget, M., & Dambrun, M. (2015). Mindfulness meditation and relaxation training increases time sensitivity. Consciousness and Cognition, 31, 86–97. doi:10.1016/j.concog.2014.10.007
   PubMed Web of Science ®Google Scholar
• Dyck, E. (2006). ‘Hitting Highs at Rock Bottom’: LSD treatment for alcoholism, 1950-1970. Social History of Medicine, 19, 313–329. doi:10.1093/shm/hkl039
   Web of Science ®Google Scholar
• Emerson, R. W. (1836) Nature. Reprinted in Ralph Waldo Emerson, selected essays (1982). New York: Penguin.
   Google Scholar
• Galinsky, A. D., Gruenfeld, D. H., & Magee, J. C. (2003). From power to action. Journal of Personality and Social Psychology, 85, 453–466. doi:10.1037/0022-3514.85.3.453
   PubMed Web of Science ®Google Scholar
• Gallagher, S., Reinerman-Jones, L., Sollins, B., & Janz, B. (2014). Using a simulated environment to investigate experiences reported during space travel. Theoretical Issues in Ergonomics Science, 15, 376–394. doi:10.1080/1463922X.2013.869370
   Google Scholar
• Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014). Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. The Journal of Nervous and Mental Disease, 202, 513–520. doi:10.1097/NMD.0000000000000113
   PubMed Web of Science ®Google Scholar
• Gasser, P., Kirchner, K., & Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology (Oxford), 29, 57–68. doi:10.1177/0269881114555249
   PubMed Web of Science ®Google Scholar
• Gordon, A. M., Stellar, J. E., Anderson, C. L., McNeil, G. D., Loew, D., & Keltner, D. (2017). The dark side of the sublime: Distinguishing a threat-based variant of awe. Journal of Personality and Social Psychology, 113, 310–328. doi:10.1037/pspp0000120
   PubMed Web of Science ®Google Scholar
• Gowdy, J., & Krall, L. (2016). The economic origins of ultrasociality. Behavioral and Brain Sciences, 39, e92. doi:10.1017/S0140525X1500059X
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford), 30, 1181–1197. doi:10.1177/0269881116675513
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology, 218, 649–655. doi:10.1007/s00213-011-2358-5
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Johnson, M. W., Richards, W. A, Richards, B. D., Jesse, R., MacLean, K. A., … Klinedinst, M. A. (2018). Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology, 32, 49–69. doi:10.1177/0269881117731279
   PubMed Web of Science ®Google Scholar
• Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford), 22, 621–632. doi:10.1177/0269881108094300
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187, 268–283. doi:10.1007/s00213-006-0457-5
   PubMed Web of Science ®Google Scholar
• Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68, 71–78. doi:10.1001/archgenpsychiatry.2010.116
   PubMed Web of Science ®Google Scholar
• Hall, S. E., Schubert, E., & Wilson, S. J. (2016). The role of trait and state absorption in the enjoyment of music. PLoS ONE, 11, e0164029. doi:10.1371/journal.pone.0164029
   PubMed Web of Science ®Google Scholar
• Hayes, A. M., Laurenceau, J.-P., Feldman, G., Strauss, J. L., & Cardaciotto, LAnn. (2007). Change is not always linear: The study of nonlinear and discontinuous patterns of change in psychotherapy. Clinical Psychology Review, 27, 715–723. doi:10.1016/j.cpr.2007.01.008
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S. (2014). Back to the future: A return to psychedelic treatment models for addiction. Journal of Psychopharmacology (Oxford), 28, 981–982. doi:10.1177/0269881114550935
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. (2014). Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology (Oxford), 28, 62–66. doi:10.1177/0269881113513851
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Crawford, M. S., & Cropsey, K. L. (2018). The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology, 32, 37–48. doi:10.1177/0269881117735685
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29, 280–288. doi:10.1177/0269881114565653
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Johnson, M. W., & Griffiths, R. R. (2015). Psilocybin, psychological distress, and suicidality. Journal of Psychopharmacol. (Oxford), 29, 1041–1043. doi:10.1177/0269881115598338
   PubMed Web of Science ®Google Scholar
• Jim, H. S., & Jacobsen, P. B. (2008). Posttraumatic stress and posttraumatic growth in cancer survivorship: A review. Cancer Journal (Sudbury, Mass.), 14, 414–419. doi:10.1097/PPO.0b013e31818d8963
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacol. (Oxford), 28, 983–992. doi:10.1177/0269881114548296
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017). Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse, 43, 55–60. doi:10.3109/00952990.2016.1170135
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacol. (Oxford), 22, 603–620. doi:10.1177/0269881108093587
   PubMed Web of Science ®Google Scholar
• Keltner, D., & Haidt, J. (2003). Approaching awe, a moral, spiritual, and aesthetic emotion. Cogn Emot, 17, 297–314. doi:10.1080/02699930302297
   PubMed Web of Science ®Google Scholar
• Keng, S. L., Smoski, M. J., & Robins, C. J. (2011). Effects of mindfulness on psychological health: A review of empirical studies. Clinical Psychology Review, 31, 1041–1056. doi:10.1016/j.cpr.2011.04.006
   PubMed Web of Science ®Google Scholar
• Kleber, H. D. (2016). The successful return of psychedelics to psychiatry. Journal of Psychopharmacol. (Oxford), 30, 1211. doi:10.1177/0269881116675779
   PubMed Web of Science ®Google Scholar
• Koltko-Rivera, M. E. (2006). Rediscovering the later version of Maslow’s hierarchy of needs: Self-transcendence and opportunities for theory, research, and unification. Review of General Psychology, 10, 302–317. doi:10.1037/1089-2680.10.4.302
   Web of Science ®Google Scholar
• Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2016). LSD-induced entropic brain activity predicts subsequent personality change. Human Brain Mapping, 37, 3203–3213. doi:10.1002/hbm.23234
   PubMed Web of Science ®Google Scholar
• MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacol. (Oxford), 25, 1453–1461. doi:10.1177/0269881111420188
   PubMed Web of Science ®Google Scholar
• Maclean, K. A., Leoutsakos, J.-M.S., Johnson, M. W., & Griffiths, R. R. (2012). Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin. Journal for the Scientific Study of Religion, 51, 721–737. doi:10.1111/j.1468-5906.2012.01685.x
   PubMed Web of Science ®Google Scholar
• Majić, T., Schmidt, T. T., & Gallinat, J. (2015). Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Journal of Psychopharmacol. (Oxford), 29, 241–253. doi:10.1177/0269881114568040
   PubMed Web of Science ®Google Scholar
• McGlothlin, W., Cohen, S., & McGlothlin, M. S. (1967). Long lasting effects of LSD on normals. Archives of General Psychiatry, 17, 521–532. doi:10.1001/archpsyc.1967.01730290009002
   PubMed Web of Science ®Google Scholar
• Metzner, R. (1998). Hallucinogenic drugs and plants in psychotherapy and shamanism. Journal of Psychoactive Drugs, 30, 333–341. doi:10.1080/02791072.1998.10399709
   PubMed Web of Science ®Google Scholar
• Nau, F., Yu, B., Martin, D., & Nichols, C. D. (2013). Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo. PLoS One, 8, e75426. doi:10.1371/journal.pone.0075426
   PubMed Web of Science ®Google Scholar
• Niedenthal, P. M., & Brauer, M. (2012). Social functionality of human emotion. Annual Review of Psychology, 63, 259–285. doi:10.1146/annurev.psych.121208.131605
   PubMed Web of Science ®Google Scholar
• Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68, 264–355. doi:10.1124/pr.115.011478
   PubMed Web of Science ®Google Scholar
• Nichols, D. E., Johnson, M. W., & Nichols, C. D. (2017). Psychedelics as medicines: An emerging new paradigm. Clinical Pharmacology and Therapeutics, 101, 209–219. doi:10.1002/cpt.557
   PubMed Web of Science ®Google Scholar
• Nour, M. M., & Carhart-Harris, R. L. (2017). Psychedelics and the science of self-experience. British Journal of Psychiatry, 210, 177–179. doi:10.1192/bjp.bp.116.194738
   PubMed Web of Science ®Google Scholar
• Nour, M. M., Evans, L., & Carhart-Harris, R. L. (2017). Psychedelics, personality and political perspectives. Journal of Psychoactive Drugs, 49, 182–191. doi:10.1080/02791072.2017.1312643
   PubMed Web of Science ®Google Scholar
• Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016). Ego-dissolution and psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience, 10, 269. doi:10.3389/fnhum.2016.00269
   PubMed Web of Science ®Google Scholar
• Nowak, M. A. (2006). Five rules for the evolution of cooperation. Science, 314, 1560–1563. doi:10.1126/science.1133755
   PubMed Web of Science ®Google Scholar
• Nusbaum, E. C., & Silvia, P. J. (2011). Shivers and timbres: Personality and the experience of chills from music. Social Psychological and Personality Science, 2, 199–204. doi:10.1177/1948550610386810
   Web of Science ®Google Scholar
• Nutt, D. (2016). Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future. Journal of Psychopharmacol. (Oxford), 30, 1163–1164. doi:10.1177/0269881116675754
   PubMed Web of Science ®Google Scholar
• Osório, F. deL, Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., … Hallak, J. E. (2015). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista Brasileira Psiquiatria, 37, 13–20. doi:10.1590/1516-4446-2014-1496
   PubMed Web of Science ®Google Scholar
• Pahnke, W. (1964) First impressions of first LSD experience of March 30, 1964. Retrieved from http://earchives.lib.purdue.edu/cdm/singleitem/collection/psyc/id/7
   Google Scholar
• Piff, P. K., Dietze, P., Feinberg, M., Stancato, D. M., & Keltner, D. (2015). Awe, the small self, and prosocial behavior. Journal of Personality and Social Psychology, 108, 883–899. doi:10.1037/pspi0000018
   PubMed Web of Science ®Google Scholar
• Pilgrim, L., Norris, J. I., & Hackathorn, J. (2017). Music is awesome: Influences of emotion, personality, and preference on experienced awe. Journal of Consumer Behaviour, 16, 442–451. doi:10.1002/cb.1645
   Web of Science ®Google Scholar
• Pisano, V. D., Putnam, N. P., Kramer, H. M., Franciotti, K. J., Halpern, J. H., & Holden, S. C. (2017). The association of psychedelic use and opioid use disorders among illicit users in the United States. Journal of Psychopharmacol. (Oxford), 31, 606–613. doi:10.1177/0269881117691453
   PubMed Web of Science ®Google Scholar
• Prade, C., & Saroglou, V. (2016). Awe’s effects on generosity and helping. The Journal of Positive Psychology, 11, 522–530. doi:10.1080/17439760.2015.1127992
   Web of Science ®Google Scholar
• Preston, J. L., & Shin, F. (2017). Spiritual experiences evoke awe through the small self in both religious and non-religious individuals. Journal of Experimental Social Psychology, 70, 212–221. doi:10.1016/j.jesp.2016.11.006
   Web of Science ®Google Scholar
• Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., … Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacol. (Oxford), 30, 1165–1180. doi:10.1177/0269881116675512
   PubMed Web of Science ®Google Scholar
• Rudd, M., Vohs, K. D., & Aaker, J. (2012). Awe expands people’s perception of time, alters decision making, and enhances well-being. Psychological Science, 23, 1130–1136. doi:10.1177/0956797612438731
   PubMed Web of Science ®Google Scholar
• Sanches, R. F., de Lima Osório, F., Dos Santos, R. G., Macedo, L. R. H., Maia-de-Oliveira, J. P., Wichert-Ana, L., … Hallak, J. E. C. (2016). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. Journal of Clinical Psychopharmacology, 36, 77–81. doi:10.1097/JCP.0000000000000436
   PubMed Web of Science ®Google Scholar
• Savage, C., & McCabe, O. L. (1973). Residential psychedelic (LSD) therapy for the narcotic addict. A controlled study. Archives of General Psychiatry, 28, 808–814. doi:10.1001/archpsyc.1973.01750360040005
   PubMed Web of Science ®Google Scholar
• Shiota, M. N., Campos, B., Oveis, C., Hertenstein, M. J., Simon-Thomas, E., & Keltner, D. (2017). Beyond happiness: Building a science of discrete positive emotions. Am Psychol, 72, 617–643. doi:10.1037/a0040456
   PubMed Web of Science ®Google Scholar
• Shiota, M. N., Keltner, D., & John, O. P. (2006). Positive emotion dispositions differentially associated with big five personality and attachment style. The Journal of Positive Psychology, 1, 61–71. doi:10.1080/17439760500510833
   Google Scholar
• Shiota, M. N., Keltner, D., & Mossman, A. (2007). The nature of awe: Elicitors, appraisals, and effects on self-concept. Cognition and Emotion, 21, 944–963. doi:10.1080/02699930600923668
   Web of Science ®Google Scholar
• Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., … Riba, J. (2016). Exploring the therapeutic potential of Ayahuasca: Acute intake increases mindfulness-related capacities. Psychopharmacology, 233, 823–829. doi:10.1007/s00213-015-4162-0
   PubMed Web of Science ®Google Scholar
• Stellar, J. E., Gordon, A., & Anderson, C. L. (2018). Awe and humility. Journal of Personality and Social Psychology, 114, 258–269. doi:10.1037/pspi0000109
   PubMed Web of Science ®Google Scholar
• Stellar, J. E., John-Henderson, N., Anderson, C. L., Gordon, A. M., McNeil, G. D., & Keltner, D. (2015). Positive affect and markers of inflammation: Discrete positive emotions predict lower levels of inflammatory cytokines. Emotion, 15, 129–133. doi:10.1037/emo0000033
   PubMed Web of Science ®Google Scholar
• Studerus, E., Gamma, A., Kometer, M., & Vollenweider, F. X. (2012). Prediction of psilocybin response in healthy volunteers. PLoS One, 7, e30800. doi:10.1371/journal.pone.0030800
   PubMed Web of Science ®Google Scholar
• Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., … Carhart-Harris, R. (2016). Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr. Biol, 26, 1043–1050. doi:10.1016/j.cub.2016.02.010
   PubMed Web of Science ®Google Scholar
• Tellegen, A., & Atkinson, G. (1974). Openness to absorbing and self-altering experiences (“absorption”), a trait related to hypnotic susceptibility. Journal of Abnormal Psychology, 83, 268–277. doi:10.1037/h0036681
   PubMed Web of Science ®Google Scholar
• Thomas, G., Lucas, P., Capler, N. R., Tupper, K. W., & Martin, G. (2013). Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews, 6, 30–42. doi:10.2174/15733998113099990003
   PubMedGoogle Scholar
• Valdesolo, P., & Graham, J. (2014). Awe, uncertainty, and agency detection. Psychological Science, 25, 170–178. doi:10.1177/0956797613501884
   PubMed Web of Science ®Google Scholar
• Van Cappellen, P., & Saroglou, V. (2012). Awe activates religious and spiritual feelings and behavioral intentions. Psychology of Religion and Spirituality, 4, 223–236. doi:10.1037/a0025986
   Web of Science ®Google Scholar
• Van Elk, M., Karinen, A., Specker, E., Stamkou, E., & Baas, M. (2016). ‘Standing in awe’: The effects of awe on body perception and the relation with absorption. Collabra, 2, 4. doi:10.1525/collabra.36
   Google Scholar
• Walsh, Z., Hendricks, P. S., Smith, S., Kosson, D. S., Thiessen, M. S., Lucas, P., & Swogger, M. T. (2016). Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. Journal of Psychopharmacol. (Oxford), 30, 601–607. doi:10.1177/0269881116642538
   PubMed Web of Science ®Google Scholar
• Wood, A. M., Froh, J. J., & Geraghty, A. W. A. (2010). Gratitude and well-being: A review and theoretical integration. Clinical Psychology Review, 30, 890–905. doi:10.1016/j.cpr.2010.03.005
   PubMed Web of Science ®Google Scholar
• Yaden, D. B., Le Nguyen, K. D., Kern, M. L., Belser, A. B., Eichstaedt, J. C., Iwry, J., … Newberg, A. B. (2017). Of roots and fruits: A comparison of psychedelic and nonpsychedelic mystical experiences. Journal of Humanistic Psychology, 57, 338–353. doi:10.1177/0022167816674625
   Web of Science ®Google Scholar
• Yaden, D. B., Iwry, J., Slack, K. J., Eichstaedt, J. C., Zhao, Y., Vaillant, G. E., & Newberg, A. B. (2016). The overview effect: Awe and self-transcendent experience in space flight. Psychology of Consciousness: Theory, Research, and Practice, 3, 1–11. doi:10.1037/cns0000086
   Google Scholar
• Yang, Y., Yang, Z., Bao, T., Liu, Y., & Passmore, H.-A. (2016). Elicited awe decreases aggression. Journal of Pacific Rim Psychology, 10, e11. doi:10.1017/prp.2016.8
   Web of Science ®Google Scholar
• Yu, B., Becnel, J., Zerfaoui, M., Rohatgi, R., Boulares, A. H., & Nichols, C. D. (2008). Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency. The Journal of Pharmacology and Experimental Therapeutics, 327, 316–323. doi:10.1124/jpet.108.143461
   PubMed Web of Science ®Google Scholar
• Zhang, J. W., Piff, P. K., Iyer, R., Koleva, S., & Keltner, D. (2014). An occasion for unselfing: Beautiful nature leads to prosociality. Journal of Environmental Psychology, 37, 61–72. doi:10.1016/j.jenvp.2013.11.008
   Web of Science ®Google Scholar
• Zoellner, T., & Maercker, A. (2006). Posttraumatic growth in clinical psychology - a critical review and introduction of a two component model. Clinical Psychology Review, 26, 626–653. doi:10.1016/j.cpr.2006.01.008
   PubMed Web of Science ®Google Scholar